Home
Company
About us
Genito-urinary diseases
Governance
Board of Directors
Scientific Advisory Board
Management
R&D
Pipeline
Litoxetine (IXA-001)
IXA-002 & IXA-003
MAGenTA
Press
Contact
Catégorie : Press
Home
/
Press
Article
Press Release, Ixaltis – Positive Results from phase 2 studies for Litoxetine, October 2019
Article
Press Release, Ixaltis-Successful Completion of phase 2 for Litoxetine, May 2019
Article
Press Release, Ixaltis-Completion of recruitment in EU/Canada, July 2018
Article
Press Release, Ixaltis-US Study starts, April 2018
Article
Press Release, Ixaltis-IND, October 2017
Article
Press Release, Ixaltis-Xigen, October 2017
Article
Biotech Finance, Avril 2017
Article
Start of Phase 2 Clinical Trial, March 2017
Article
Presentation of abstracts at EAU 2017, March 2017
Article
Abstract 2/2 EAU 2017 – Effects of litoxetine on acetic acid-induced
1
2
